Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 6Completed 6Withdrawn 3Active not recruiting 3Unknown 2Terminated 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Urinary Bladder Neoplasms 3Urinary Bladder Neck Obstruction 1Urinary Bladder Calculi 1Nephrolithiasis 1Kidney Diseases 1Carcinoma, Transitional Cell 1

Interventions

tremelimumab 4Cystoscopy 3durvalumab 2avelumab 2Paclitaxel 2Gemcitabine 2Docetaxel 2Cisplatin 2vocimagene amiretrorepvec 1vinflunine 1trebananib 1trastuzumab duocarmazine 1pegfilgrastim 1merphos 1infigratinib 1erdafitinib 1efineptakin alfa 1copanlisib 1atezolizumab 1Vinblastine 1Trastuzumab 1Taxes 1TAS-116 1Specimen Handling 1Sirolimus 1Rosiglitazone 1Ropivacaine 1Rogaratinib 1Radiotherapy 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Urinary Bladder Neoplasms × Cystoscopy × Clear all
NCT05564416 2025-10-21

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

National Cancer Institute (NCI)

Phase 2 Withdrawn
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06422312 2025-04-04

A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.

Guangzhou Red Pine Medical Instrument Co., Ltd.

Phase NA Withdrawn
Genitourinary

Urinary Bladder Calculi, Urinary Bladder Neck Obstruction, Urinary Bladder Neoplasms, Kidney Diseases, Nephrolithiasis

NCT05260788 2022-04-14

Mapping 3D Bladder

University Health Network, Toronto

Withdrawn
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡